Published

Advancing cancer neuroscience through stress modulation: Interdisciplinary potential of psilocybin and ketamine

No abstract is available for this record.

Open source BibTeX RIS

Bibliographic context

Journal: General Hospital Psychiatry
Date: 2026-02-24
Source: OpenAlex
DOI: 10.1016/j.genhosppsych.2026.02.011
PubMed: 41762772

Authors

Alan C. Courtes Blake Myers Noah Daly Greg Jones Jair C. Soares Carlos A. Zarate Rodrigo Machado-Vieira

Watch author

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Advancing cancer neuroscience through stress modulation: Interdisciplinary potential of psilocybin and ketamine2026-02-24

Related papers

The Utility of Psilocybin in Managing Anxiety and Depression in Cancer PatientsBiochemistry and Molecular Biology Education · 2018-07-31 Psilocybin may help cancer patients with depression and anxiety for yearsAccess Science · 2019-12-31 Psilocybin to Manage Cancer-Related DepressionUnknown journal · 2016-12-20 Repurposing of recreational drugs: will these new ‘medicines’ (e.g., psychedelics, psilocybin, cannabinoids, LSD, MDMA, ketamine) deliver short- or longer-term benefits for those with depressive or other mood disorders?Research Directions Depression · 2023-10-12 Psychedelics: A new era of treatment?Unknown journal · 2021-08-12 S1 Appendix - Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trialFigshare · 2025-09-18 Can Psilocybin Treat Severe DepressionJournal watch · 2017-11-02